Susquehanna International Group, LLP Connect Biopharma Holdings LTD Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.01 - $1.25 $10,302 - $12,750	-10,200 Reduced 49.35%	10,470 $11,000
Q1 2023 May 16, 2023	SELL	$0.82 - $1.32 $217 - $349	-265 Reduced 1.27%	20,670 $20,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.31 $13,398 - $27,424	20,935 New	20,935 $18,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $3.25 $1,737 - $10,081	-3,102 Reduced 19.13%	13,110 $11,000
Q4 2021 Feb 14, 2022	BUY	$4.26 - $23.33 $69,063 - $378,225	16,212 New	16,212 $83,000

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $54.5M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.